Learn more

NEWISH TECH BEIJING CO LTD

Overview
  • Total Patents
    14
  • GoodIP Patent Rank
    130,880
About

NEWISH TECH BEIJING CO LTD has a total of 14 patent applications. Its first patent ever was published in 2011. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and measurement are FORBIO RES PTY LTD, PROIZV OB BIOLAR N and JIANGSU QIANYAOTANG STATE MEDICAL RES INST CO LTD.

Patent filings in countries

World map showing NEWISH TECH BEIJING CO LTDs patent filings in countries

Patent filings per year

Chart showing NEWISH TECH BEIJING CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Sun Zhongjie 12
#2 Guo Xiao 10
#3 Chen Ligong 10
#4 Liu Defang 10
#5 Wang Xiaofang 6
#6 Qi Hailong 6
#7 Xiao Xiong 5
#8 Ma Junfan 4
#9 Xue Qinglei 3
#10 Yang Huan 3

Latest patents

Publication Filing date Title
CN110799641A Application of sodium butyrate and culture system containing sodium butyrate
WO2020057107A1 Composition and use thereof
CN109593714A The cultivating system of amplifying candidate stem cell, method and application thereof
CN109593716A The cultivating system of amplifying candidate stem cell, method and application thereof
CN109468277A The cultivating system of amplifying candidate stem cell, method and application thereof
CN109609455A The cultivating system of amplifying candidate stem cell, method and application thereof
CN109207426A A method of hematopoietic progenitor cells are changed into candidate stem cell
CN109207427A A method of hematopoietic progenitor cells are changed into candidate stem cell
CN109706119A The cultivating system of amplifying candidate stem cell, method and application thereof
CN108486055A Culture medium and its application in central memory-type T lymphocyte cultures
WO2019127697A1 Culture system for amplifying hematopoietic stem cell and/or hematopoietic progenitor cell and method therefor, hematopoietic stem cell and hematopoietic progenitor cell